Concepedia

Ramachandran Rashmi

RR

Statistics

Publications

13

Citations

828

H-Index

13

Active since

2003

Affiliations

Rajiv Gandhi Centre for Biotechnology(Current)

Saint Louis University

Washington University in St. Louis

The University of Texas MD Anderson Cancer Center

Mallinckrodt (United States)

Ramachandran Rashmi is an author at Rajiv Gandhi Centre for Biotechnology specializing in oncology, medicine, and molecular oncology.

Publications per year

2003–2018

13

Publications

13

Human colon cancer cells differ in their sensitivity to curcumin‐induced apoptosis and heat shock protects them by inhibiting the release of apoptosis‐inducing factor and caspases

Ramachandran Rashmi, T. R. Santhosh Kumar, Devarajan Karunagaran · FEBS Letters · 2003 · 120 citations

Medicine, Cancer Biology, Oncology +15

Pathway-Specific Analysis of Gene Expression Data Identifies the PI3K/Akt Pathway as a Novel Therapeutic Target in Cervical Cancer

Julie K. Schwarz, Jacqueline E. Payton, Ramachandran Rashmi et al. · Clinical Cancer Research · 2012 · 100 citations

Medicine, Cancer Biology, Oncology +17

AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake

Ramachandran Rashmi, Carl J. DeSelm, Cynthia Helms et al. · PLoS ONE · 2014 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism

Ramachandran Rashmi, Xiaojing Huang, John M. Floberg et al. · Cancer Research · 2018 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL

Ramachandran Rashmi · Carcinogenesis · 2005 · 79 citations · Full text

Medicine, Cell Biology, Oncology +15

1–5 of 13